Orbis Boosts Oral Macrocycle Platform With Gefion AI
03 Jun 2025 //
BUSINESSWIRE
Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair
05 Mar 2025 //
BUSINESSWIRE
Orbis Medicines Secures Funding For Oral Macrocycles Pipeline
07 Jan 2025 //
CONTRACTPHARMA
Orbis Medicines to Expand With New R&D Site in Copenhagen
03 Oct 2024 //
BUSINESSWIRE
Orbis And Vivtex Collaborate To Develop Orally Dosable Next-Gen nCycles
17 Sep 2024 //
BUSINESSWIRE